Open tracheostomy in patients with dual platelet aggregation inhibitors: case series

  • Lorena Zapata-Contreras Universidad de Caldas, Manizales, Colombia.
  • Carlos Eduardo Hoyos-Cuervo Hospital Departamental Santa Sofía de Caldas, Manizales, Colombia.
  • María Cristina Florián-Pérez a. Hospital Departamental Santa Sofía de Caldas, Manizales, Colombia. b. Anesthesiology Postgraduate Program, Universidad de Caldas, Manizales, Colombia.
Keywords: Tracheostomy, Platelet Aggregation Inhibitors, Hemorrhage, Intraoperative Complications, Anticoagulants

Abstract

Introduction:

Tracheostomy is the most common surgical procedure performed in the intensive care unit (ICU). There is a paucity of evidence regarding complications in patients on dual anti-platelet therapy.

Objective:

To describe the complications arising in critically ill patients on dual antiplatelet therapy who are subjected to open tracheostomy.

Method:

Descriptive observational study of a retrospective case series of patients admitted to the ICU between June 2011 and December 2016, scheduled to undergo open tracheostomy.

Results:

Overall, 52 patients met the inclusion criteria and, of them, 14 were excluded. Postoperatively, 4 patients (10.5%) had major bleeding and 2 (5.3%) had minor bleeding. Only 1 patient (2.6%) required transfusion secondary to tracheostomy-related bleeding. No patient required fiberoptic bronchoscopy due to bleeding. Reintervention was needed in 10.5% of patients (n=4). No tracheostomy-related mortality was reported.

Conclusion:

Although 10.5% of patients had major bleeding, there was no impact on mortality. This study showed that, in patients with recent major cardiovascular events, there is no need to discontinue dual antiplatelet therapy or delay tracheostomy.

References

1. Cipriano A, Mao M, Hon H, et al. An overview of complications associated with open and percutaneous tracheostomy procedures. Int J Crit Illn Inj Sci 2015;5:179.

2. De Leyn P, Bedert L, Delcroix M, et al. Tracheotomy: clinical review and guidelines. Eur J Cardiothoracic Surg 2007;32:412-421.

3. Szmuk P, Ezri T, Evron S, et al. A brief history of tracheostomy and tracheal intubation, from the Bronze Age to the Space Age. Intensive Care Med 2008;34:222-228.

4. Breedveld DP, Dongelmans D, Van Der Hoeven JG, et al. Tracheostomy on the intensive care unit for adult patients. Neth J Crit Care 2007;11:324-328.

5. Voigt I, Naber C. Bleeding complications of percutaneous dilatation tracheostomy (PDT) in a group of ICU patients with dual antiplatelet therapy. Crit Care Shock 2012;15:2-8.

6. Bradley PJ. Bleeding around a tracheostomy wound: what to consider and what to do? J Laryngol Otol 2009;123:952-956.

7. Veelo DP, Vlaar AP, Dongelmans DA, et al. Correction of subclinical coagulation disorders before percutaneous dilatational tracheotomy. A randomized controlled trial. Blood Transfus 2012;10:213-220.

8. Oprea AD, Popescu WM. Perioperative management of antiplatelet therapy. Br J Anaesth 2013;111 (suppl 1):3-17.

9. Antithrombotic Trialists’ Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.

10. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014;35:2383-2431.

11. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014;130:e278-e333.

12. Markota A, Sinkovic A, Ccizmarevic B. Surgical tracheotomy performed with and without dual antiplatelet therapy. Open Med 2015;10:101-105.

13. Abouzgheib W, Meena N, Jagtap P, et al. Percutaneous dilational tracheostomy in patients receiving antiplatelet therapy is it safe? J Bronchol Interv Pulmonol 2013;20:322-325.

14. Nam SJ, Park JY, Lee H, et al. Percutaneous dilatational tracheostomy in critically ill patients taking antiplatelet agents. Korean J Crit Care Med 2014;29:183-188.

15. Brass P, Hellmich M, Ladra A, et al. Percutaneous techniques versus surgical techniques for tracheostomy. Cochrane Database of Systematic Reviews. 2016:CD008045. DOI: 10.1002/14651858. CD008045.pub2.
How to Cite
1.
Zapata-Contreras L, Hoyos-Cuervo CE, Florián-Pérez MC. Open tracheostomy in patients with dual platelet aggregation inhibitors: case series. Colomb. J. Anesthesiol. [Internet]. 2019 Jul. 1 [cited 2022 Oct. 3];47(3):189-93. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/83

Downloads

Download data is not yet available.
Published
2019-07-01
How to Cite
1.
Zapata-Contreras L, Hoyos-Cuervo CE, Florián-Pérez MC. Open tracheostomy in patients with dual platelet aggregation inhibitors: case series. Colomb. J. Anesthesiol. [Internet]. 2019 Jul. 1 [cited 2022 Oct. 3];47(3):189-93. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/83
Section
Case Report / Case Series